Northern Trust Corp Sells 562,535 Shares of 23andMe Holding Co. (NASDAQ:ME)

Northern Trust Corp lowered its position in shares of 23andMe Holding Co. (NASDAQ:ME) by 95.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 29,527 shares of the company’s stock after selling 562,535 shares during the quarter. Northern Trust Corp owned about 0.11% of 23andMe worth $96,000 as of its most recent SEC filing.

Separately, Leavell Investment Management Inc. acquired a new position in shares of 23andMe during the fourth quarter valued at about $32,000. 36.10% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of 23andMe in a report on Saturday, March 22nd.

23andMe Stock Down 35.3%

23andMe stock opened at $0.50 on Wednesday. 23andMe Holding Co. has a twelve month low of $0.53 and a twelve month high of $10.81. The firm has a 50 day moving average price of $0.50 and a 200-day moving average price of $2.03. The company has a market capitalization of $13.36 million, a P/E ratio of -0.03 and a beta of 1.19.

About 23andMe

23andMe Holding Co operates as a consumer genetics testing company. The company operates in two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications.